Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 May;59(5):866-879.
doi: 10.1080/02770903.2021.1888116. Epub 2021 Apr 1.

Asthma and risk of infection, hospitalization, ICU admission and mortality from COVID-19: Systematic review and meta-analysis

Affiliations
Meta-Analysis

Asthma and risk of infection, hospitalization, ICU admission and mortality from COVID-19: Systematic review and meta-analysis

Anthony P Sunjaya et al. J Asthma. 2022 May.

Abstract

Objective: As COVID-19 spreads across the world, there are concerns that people with asthma are at a higher risk of acquiring the disease, or of poorer outcomes. This systematic review aimed to summarize evidence on the risk of infection, severe illness and death from COVID-19 in people with asthma.

Data sources and study selection: A comprehensive search of electronic databases including preprint repositories and WHO COVID-19 database was conducted (until 26 May 2020). Studies reporting COVID-19 in people with asthma were included. For binary outcomes, we performed Sidik-Jonkman random effects meta-analysis. We explored quantitative heterogeneity by subgroup analyses, meta regression and evaluating the I2 statistic.

Results: Fifty-seven studies with an overall sample size of 587 280 were included. The prevalence of asthma among those infected with COVID-19 was 7.46% (95% CI = 6.25-8.67). Non-severe asthma was more common than severe asthma (9.61% vs. 4.13%). Pooled analysis showed a 14% risk ratio reduction in acquiring COVID-19 (95% CI = 0.80-0.94; p < 0.0001) and 13% reduction in hospitalization with COVID-19 (95% CI = 0.77-0.99, p = 0.03) for people with asthma compared with those without. There was no significant difference in the combined risk of requiring admission to ICU and/or receiving mechanical ventilation for people with asthma (RR = 0.87 95% CI = 0.94-1.37; p = 0.19) and risk of death from COVID-19 (RR = 0.87; 95% CI = 0.68-1.10; p = 0.25).

Conclusion: The findings from this study suggest that the prevalence of people with asthma among COVID-19 patients is similar to the global prevalence of asthma. The overall findings suggest that people with asthma have a lower risk than those without asthma for acquiring COVID-19 and have similar clinical outcomes.

Keywords: Severe acute respiratory syndrome coronavirus 2; coronavirus; critical care medicine; meta-analysis; novel coronavirus 2019; respiratory infections; ventilator support.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflict of interest. AS is in receipt of a UNSW Scientia PhD scholarship.

Figures

Figure 1.
Figure 1.
PRISMA study selection flow chart.
Figure 2.
Figure 2.
Quality of studies assessment.
Figure 3.
Figure 3.
Risk of acquiring COVID-19 in people with asthma compared to no asthma.
Figure 4.
Figure 4.
Risk of severe illness from COVID-19 among those with asthma compared to no asthma.
Figure 5.
Figure 5.
Risk of death against recovered from COVID-19 among those with asthma compared to no asthma.

References

    1. Maria DVK, Sadoof A, Abdullah A, Ranawaka APMP, Malik P, Hassan EEB, Abdulaziz AB.. Transmissibility of MERS-CoV infection in closed setting, Riyadh, Saudi Arabia, 2015. Emerg Infect Dis J. 2019;25(10):1802. doi: 10.3201/eid2510.190130. - DOI - PMC - PubMed
    1. Oliver BG, Robinson P, Peters M, Black J.. Viral infections and asthma: an inflammatory interface? Eur Respir J. 2014;44(6):1666–1681. doi: 10.1183/09031936.00047714. - DOI - PubMed
    1. US CDC . COVID-NET Preliminary Data 30 May 2020. Available from: https://gis.cdc.gov/grasp/COVIDNet/COVID19_5.html [last accessed 6 June 2020].
    1. Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, Shi J, Zhou M, Wu B, Yang Z, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146(1):110–118. doi: 10.1016/j.jaci.2020.04.006. - DOI - PMC - PubMed
    1. NICE UK . COVID-19 rapid guideline: Severe asthma; 2020. - PubMed

Publication types